Introduction
Cellular signaling and regulation are frequently mediated by proteins that lack stable tertiary structures under physiological conditions [1] [2] [3] . Such intrinsically disordered protein (IDPs) tend to be enriched with charged and polar residues and at the same time lack large hydrophobic residues that are needed for independent folding 4 . As a result, the native states of IDPs correspond to ensembles of heterogeneous and dynamic conformations instead of stably folded structures. Sequence analysis has revealed that intrinsic disorder is highly prevalent in proteomes, with about one-third of eukaryotic proteins predicted to contain disordered segments of >40 residues 5 . The prevalence of intrinsic disorder suggests that conformational heterogeneity (and flexibility) confer important functional advantages, especially in cellular signaling and regulation. Many potential benefits of intrinsic disorder have been discussed, such as larger binding surface areas, inducibility by posttranslational modifications (PTMs), and structural plasticity for binding multiple partners [6] [7] [8] [9] . Interestingly, regulatory IDPs frequently fold into stable structures upon specific binding 10 . Such coupled binding and folding allows weaker binding to be achieved without compromising specificity, as the entropic cost of folding offsets the stabilization effects of forming many specific contacts. A reduced binding affinity, in turn, allows higher dissociation rates, which could be an important advantage in signaling and regulation 11 .
Coupled binding and folding provides a convenient framework for understanding the structural basis of IDP recognition and regulation, and it has been one of the primary focuses in IDP studies 10;12;13 . Yet, examples have began to emerge where substantial conformational heterogeneity, and sometimes full disorder of the entire binding domain, persists in the bound states [14] [15] [16] . This led Tompa and Fuxreiter to suggest that the concept of intrinsic disorder needs to be extended to include protein complexes, arguing that "fuzziness" in the bound state could add "adaptability, versatility and reversibility to the binding of proteins and thereby an ease of regulation in protein-protein interactions" 14 . Such fuzzy complexes could include "static" and/or "dynamic" disorder 14 . A complex with static disorder, such as Tcf4/β-catenin 17 , samples a multitude of alternative folded conformations; whereas a complex with "dynamic" disorder contains unstructured segments, either as linkers between folded binding domains ("clamp" model) or as flanking tails of a globular binding domain ("flanking" model). In extreme cases, the entire binding domain could remain disordered in the bound state, and recognition relies completely on transient contacts. Examples of such "random" or "disordered" complexes include the oligomeric state of the cytoplastimic domains of T-cell receptor ζ-chains 18 and the Sic1/Cdc4 complex 19;20 . Several examples also exist where biological activities appear to be mediated by interactions free of primary sequence constraints 14 . The implication is that these complexes are disordered and do not rely on strict complementarity at the binding interface.
The recognition of the potential prevalence of disorder in protein complexes is an important one.
It requires broader consideration of how specific interactions of IDPs might be realized and regulated. For complexes with dynamic disorder 14 , establishing the structural basis of recognition becomes more involved, beyond obtaining their high-resolution structures using either X-ray crystallography or nuclear magnetic resonance (NMR); instead, conformational ensembles are required. Unfortunately, resolving heterogeneous protein conformational ensembles is a challenging problem that is often fundamentally limited by underdetermination (that is, the number of experimental restraints is insufficient to uniquely define the accessible conformational space) [21] [22] [23] . On the other hand, neglecting potential conformational heterogeneity in the bound state, such as due to lack of awareness of fuzzy complexes, could lead to misleading structural interpretations. It can be particularly problematic for ensemble methods such as NMR and Förster resonance energy transfer (FRET), where a set of independent structural restraints are first determined and then used to calculate multiple structures using restrained molecular dynamics protocols 24 . Neglecting potential disorder during structural calculation will generate overly ordered conformations with structural features that do not necessarily co-exist 23 .
The tumor suppressor p53 regulates many genes involved in cell cycle and apoptosis and is arguably one of the most important proteins in cancer 25 ; for example, over 50% of human cancers involve some alteration of p53 activities 26 . At the same time, p53 is also one of the most extensively studied IDPs, with multiple intrinsically disordered regulatory domains that mediate p53's interactions with many other proteins 27 . The C-terminal negative regulatory domain (NRD) (residues 367−392), in particular, is one of the few IDPs that have been experimentally shown to be able to fold into distinct structures upon specific binding to different targets, including α-helix, β-strand and two distinct loops 9 . One of the structures involves binding to Ca 2+ -loaded dimeric S100B(ββ), which blocks access to several phosphorylation and acetylation sites in p53-NRD and thus inhibits p53 oligomerization and transcriptional activity 28 . The level of S100B protein is correlated with malignant melanoma, and is often used as a diagnostic cancer marker 29 .
The p53/S100B interaction can also be targeted by small molecule inhibitors for restoring p53 activity in cancer therapeutics 30;31 .
A previous NMR structural study 32 suggested that p53-NRD folded into a short helix and formed a structurally stable complex when bound to S100B(ββ) (see Fig. 1 ). For example, the averaged root mean square deviations (RMSDs) of the NMR structure ensemble (PDB: 1dt7) from the mean structure are only 0.61 Å for all ordered backbone atoms and 1.44 Å when including all ordered heavy atoms 32 . Curiously, most assigned intermolecular nuclear Overhauser effects (NOEs) are extremely weak. Out of a total of 33 unique intermolecular NOEs (see Table 1), 20 were assigned an upper bound of 6 Å and 11 others an upper bound of 5 Å. There are only two medium/weak intermolecular NOEs assigned, both involving p53 Leu383. Closer examination of the NMR ensemble revealed significant uncertainty in side chain packing at the interface, with only a few intermolecular contacts consistently observed within the 40-member ensemble (e.g., see Fig. 2A and Table S1 ). It also appears that a stably formed helix spanning p53 residues 376-387 would hinder formation of extensive hydrophobic contacts between p53 nonpolar side chains (mainly Leu383 and Phe385) with the narrow but deep hydrophobic binding pocket of S100B(ββ) (see Fig. 1 ). It was suggested that Arg379 and Lys386 of p53 could form salt bridges with Glu45 and Glu86 of S100B(ββ), respectively 32 ; however, exposed salt-bridges are rarely stabilizing 33 . In fact, p53 Lys386 and S100B(ββ) Glu86 are spatially close enough to make saltbridge contact only ~15% of the time in the NMR ensemble (see Fig. 2A ). These observations together suggest that the p53/S100B(ββ) complex structure might not be as stable as previously thought. Interestingly, different levels of conformational instability of p53 have been observed consistently in recent atomistic simulations of the complex 31;34;35 using different force fields including Amber ff99 36 , GROMOS 53a6 37 and GBSW implicit solvent 38;39 , although force field quality has been mainly invoked to rationalize such observations. To further examine potential fuzziness and structural basis of the p53-S100B(ββ) interaction, we performed extensive all-atom explicit solvent simulations using two of the best-tested empirical protein force fields, namely, CHARMM22/CMAP [40] [41] [42] and Amber ff99SB 43 . Initiated from diverse members of the NMR ensemble, five independent simulations of the complex were carried out, allowing a total of 1.0 μs effective sampling of the p53/S100B(ββ) interface. The resulting conformational ensemble supports significant heterogeneity in p53 conformation when bound to S100B(ββ). Interestingly, such a heterogeneous ensemble appears to be highly consistent with experimentally assigned intermolecular NOEs. Clustering analysis further demonstrated that many conformational sub-states co-existed in the bound state and each satisfied a different sub-set of NOEs. Importantly, the proposed fuzzy complex structure ensemble appears to be capable of providing similar shielding of key p53 PTM sites and thus could support the inhibition of p53 activation via S100B(ββ) association.
Results

Conformational heterogeneity of the p53/S100B(ββ) interface
The p53/S100B(ββ) complex as a whole was stable, with the total Cα RMSD remaining around ~3 Å in all five independent 100-ns CHARRM production simulations (Fig. S2) . All bound calcium ions remain intact throughout all simulations. However, the p53/S100B(ββ) binding interface were highly dynamic. As shown in Fig. 3A , the (self) Cα RMSD of the p53 peptide fluctuated between 2-3 Å in most simulations but could increase up to greater than 5 Å in some cases (3 out of the 10 independent interfaces). Large self RMSD values are strongly correlated with significant loss of helicity (e.g., see final snapshots shown in Fig. S1B) . On the ensemble level (including the last 60 ns from all production trajectories), only the N-terminal region of p53 (residues 375-383) remains highly helical (with ~75% helicity), but the last helix turn (residues 384-387) is rarely formed (Fig. 3D) . The pervious experimental assignment of the p53 helical segment (376-387) was based on Hα chemical shift indexing and medium range NOE connectivity 32 . It is probable that the current simulation underestimates the helicity in the p53-NRD C-terminus. On the other hand, absence of experimentally resolved αβ i,i+3 , αN i,i+3 medium range NOEs in the last helical turn appears to be consistent with at least reduced helicity in this region. Interestingly, the Cα binding RMSD of p53 (as defined in Methods) rapidly increased to around 4-8 Å in all simulations regardless of the starting conformations. Helix unfolding clearly contributes to the large p53 binding RMSD values observed; but large binding RMSD appears to more of a consequence of substantial changes in p53 binding mode.
As illustrated in Fig. 4 , helix unwinding at the p53-NRD C-terminus allows key nonpolar residues, including Leu383 and Phe385, to penetrate deeper into the hydrophobic binding pocket of S100B(ββ) and make more extensive intermolecular contacts (see Fig. 2 ). Importantly, these hydrophobic interactions appear to play a key role in anchoring p53-NRD at the interface; for example, even though the C-terminal segment is less helical (Fig. 3D) , it displays smaller fluctuations ( Fig. 3C ). The p53-NRD N-terminus appears to be stabilized mainly by interactions between Arg379 with several Glu residues on S100(ββ), including Glu45, Glu46, Glu49 and Glu51 on the hinge between the second and third helices (see Fig. 2 and Table S1 ). The presence of multiple complimentary charges on the hinge appears to facilitate the p53-NRD N-terminus to sample alternative orientations in the bound state, leading to large fluctuations observed in simulations (Fig. 3C) . Such conformational heterogeneity reduces the entropy penalty of p53 folding upon binding, and might help to explain the ability of p53-NRD to bind S100(ββ) with a dissociation constant K D ~ 23 μM
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, despite having a small hydrophobic interface that is mainly anchored by a single hydrophobic residue (Leu383). Interestingly, although p53-NRD Lys386 was proposed to provide another anchoring point by interacting with S100(ββ) Glu86 32 , it displays a strong tendency to remain solvated. In fact, solvation of Lys386 and deeper burial of hydrophobic side chains (particularly Leu383) appear to be two key driving forces that drive the observed changes in p53-NRD conformation.
The above qualitative observations are further supported by comparing the residue-residue contact maps calculated from the NMR and simulated ensembles. The maps are shown in Fig. 2 , with all contacts observed with >0.2 probabilities listed in Table S1 . The contact analysis clearly shows that the simulated ensemble predicts the p53 segment centered at Leu383 and Phe385 to be involved in more extensive contacts than in the NMR ensemble, while either the very N-or Cterminus (particularly Lys386) makes fewer stable contacts. Interestingly, the overall pattern of contacts calculated from the simulated ensemble appears more consistent with the set of experimentally resolved (weak) intermolecular NOEs (marked as red crosses in Fig. 2 ) than the one derived from the original NMR ensemble. For example, the NMR ensemble gives rise to a sparser contact map ( Fig. 2A) , with few or no residue-residue contacts in several regions where NOEs are experimentally observed (e.g., near S100B 44 -p53 385, S100B 55 -p53 383, and S100B 55 -p53 387). In contrast, the simulated ensemble yields significantly populated contacts in these regions (Fig. 2B ). In addition, substantial conformational heterogeneity in the Nterminal segment of p53-NRD in the bound state could explain an apparent paucity of resolvable intermolecular NOEs for this region (only three very week ones were resolved; see Table 1 ). The consensus sequence of S100B-binding proteins have been suggested to contain a positive charge followed by several hydrophobic residues 44;45 ; however, the exact sequence pattern appears to
. Such variance could suggest that conformational heterogeneity observed at the p53/S100B(ββ) interface might be present in complexes formed by other S100B-binding peptides.
Validation of the simulated ensemble: force field dependence and NOE violation analysis
Importantly, the observed "fuzziness" in the p53/S100B(ββ) interface does not seem to be an artifact of the CHARMM22/CMAP force field. Substantial instabilities have been observed consistently in previous simulations of the complex using other force fields 31;34;35 . For example, p53-NRD was found to be very flexible and to unfold significantly in the bound state during a 20-ns explicit solvent simulation in the Amber ff99 force field 31 . Allen et al. found that the Cterminus of p53-NRD unfolded during one of their 100-ns explicit solvent simulations in the GROMOS 53a6 force field 34 . We have further verified the force field dependence using an additional 100-ns simulation of the complex in the Amber ff99SB force field 43 , which is arguably one of the best force fields optimized for simulating protein conformational equilibria 46 .
The results, summarized in Fig. S3 , are highly consistent with the observations from the CHARMM simulations. Specifically, the p53 helix was also observed to unfold substantially, especially at the C-terminus, to allow more extensive hydrophobic contacts with S100B(ββ) (Fig.   S3B ). Both N-and C-termini of p53-NRD remains highly dynamic in the S100B(ββ)-bound state, and substantial conformational heterogeneity exists at the interface. There is also a notable resemblance between the residue-residue contact maps shown in Fig. S3D (Amber) and Fig. 2B (CHARMM), despite the substantial difference in amount of sampling. The genuineness of the observed dynamic p53/S100B(ββ) interface is further supported by an independent simulation of the bound state using the OPLS-AA/L force field published while the current work was under review 47 . It was also observed that p53-NRD underwent substantial helix unfolding, particularly at the C-terminus, to allow more extensive contacts of the p53 segment centered at Leu383 and Phe385 with S100B((ββ).
As a more direct validation of the simulated ensemble, we back-calculated NOE-like distances between groups of atoms involved in all experimentally resolved intermolecular NOEs and compared them with the assigned upper bounds (see Methods). The results are summarized in Table 1 , and histograms of NOE-like distances between pairs of atom groups involved in six selected intermolecular NOEs are shown in Fig. 5 . The analysis shows that the simulated ensemble as a whole is highly consistent with the experimental NOE set, with only 6 of the 33 intermolecular NOEs violated by over 0.5 Å and only two violated by >2.0 Å. Both severely violated NOEs involve either Arg379 or Lys386, which, as discussed above, have a strong tendency to become solvent-exposed and likely drive the observed conformational changes (see S4 ) and divergence in the histograms of NOE-like distances calculated from different trajectories (Fig. 5) . It should be emphasized that consistency with the experimental NOE restraints, although an important validation, is not sufficient to establish the correctness of the entire heterogeneous ensemble due to underdetermination 23 . In addition, because of the r -6 averaging nature of NOE, calculated (or measured) ensemble-averaged NOE distances are not sensitive to conformations with much larger distances within the ensemble.
Clustering analysis: existence of multiple conformational sub-states
The average conformations of 8 largest clusters of the simulated ensemble identified by k-mean clustering using p53 binding C α RMSD are shown in Fig. 6 . These average structures further illustrate the broad manifold of conformational sub-states sampled by p53-NRD in the bound state. The p53 conformation itself appears to be somewhat similar in these clusters, with a rather stably formed helix at the N-terminus followed by a coiled C-terminal tail; however, substantial differences exist in the orientation of p53-NRD and specific interactions that it forms with S100B(ββ). The p53 peptide appears to pivot around Leu383, which forms many contacts with residues in the hydrophobic binding pocket of S100B(ββ) (see Fig. 2 and Table S1 ). The more helical N-terminus, stabilized mainly by electrostatic interactions, however, can sample many alternative orientations as represented by these clusters.
We have further performed NOE violation analysis on sub-ensembles of structures that belong to the 10 most populated clusters. The results are summarized in Fig. 7 . Several interesting observations can be made. First, all intermolecular NOEs are satisfied by two or more of the 10 largest clusters, including those that are (severely) violated on the whole ensemble level (e.g., R379-K48 and K386-L44; see Table 1 
Access to p53 PTM sites: inhibition of p53 activity
To examine how effectively the simulated heterogeneous ensemble can hinder access to PTM sites in p53-NRD, we analyzed the average buried surface areas of p53 residues. The results, shown in Fig. 8 , demonstrate that the profiles of residue buried surface areas from the NMR and simulated ensembles are very similar. Key PTM sites within p53-NRD include two phosphorylation sites (Ser376 and Thr377) and two acetylation sites (Arg379 and Lys386).
Clearly, all these PTM sites except Thr377 remain sterically hindered despite the dynamic nature of p53-NRD in the simulated bound state. An important difference is that Thr377 becomes fully solvent-exposed and could potentially be phosphorylated by protein Kinase C (PKC); however, the helical state of the p53-NRD N-terminal segment, coupled with steric shielding of the neighboring residues, is likely sufficient to prevent access of Thr377 to the PKC active site for efficient phosphorylation. In addition, previous in vitro experiments have showed that either S376A or T377A alone could reduce p53 activity to a level that might be achieved by cotransfection of S100B(ββ) (~50%) 48 . Therefore, the proposed heterogeneous ensemble could fully support S100(ββ) inhibition of p53 activity.
Discussion
Recent recognition of the prevalence of intrinsic disorder in biology has drastically expanded the perception of how protein structure may mediate function. Substantial progress has been made in understanding the structural basis and molecular mechanisms of IDP function, but mainly in the context of coupled binding and folding that involve well-structured bound states 10;12;13 . Examples have also emerged to suggest the generality and importance of structural disorder (or "fuzziness") in the bound state of IDPs 14;15 . This is an important recognition that requires new ways of thinking about and studying IDP interaction and regulation. In particular, conformational ensembles are necessary for describing dynamic bound states, and conventional restrained molecular dynamics-based structural calculation protocols are no longer applicable. However, important challenges exist in calculating heterogeneous structure ensembles, and this is mainly due to the fundamental limitation that ensemble-averaged properties alone do not provide sufficient constraint (information) to uniquely define representative structure ensembles for heterogeneous protein states 16;21 . Instead, with important advances in protein force fields and sampling methodologies in recent years, physics-based atomistic simulations may provide an effective alternative means to generate de novo structural ensembles of disordered proteins states 49 .
For the case of the p53/S100B(ββ) complex, analysis of the NMR data and calculated structure ensemble suggests that the p53/S100B(ββ) interface is highly dynamic. Extensive atomistic explicit solvent simulations were performed using two state-of-the-art empirical protein force fields, which consistently revealed substantial heterogeneity in the p53-NRD conformation and how it binds with S100B(ββ). Specifically, helix unwinding at the p53-NRD C-terminus allows key hydrophobic residues (Leu383 and Phe385) to make more extensive contacts with S100B(ββ); the N-terminal segment, although highly helical, displays great flexibility in its packing with S100B(ββ). Additional NMR experiments, particularly relaxation measurements, will be necessary to provide direct experimental evidence on the dynamic nature of the S100B(ββ)-bound state of p53-NRD. Nonetheless, the simulated dynamic ensemble is highly consistent with experimental intermolecular NOE restraints, and provides similar shielding of key PTM sites in p53-NRD to support S100B(ββ) inhibition of p53 activity. The simulation thus offers a plausible alternative structural interpretation of how S100B(ββ) regulate p53 activity, and provides new insights for design of rational strategies for modulating this interaction for cancer therapy. The current study also demonstrates the importance and efficacy of an integrated computational and experimental strategy for understanding fuzzy complexes.
Methods
Explicit solvent simulations
The NMR ensemble (PDB: 1dt7 32 ) consists of 40 structures and each contains two p53-NRD (residues 369-388) in complex with a Ca 2+ -loaded S100B(ββ) dimer. Five diverse conformers were first selected based on mutual backbone root-mean-square distances (RMSDs). The selected models were models 1, 21, 23, 30 and 31 from the NMR ensemble (see Fig. S1 ). These structures were then used to generate the initial configurations for independent simulations to facilitate conformational sampling. The NMR study showed that the N-terminal segment of p53-NRD (residues 369-373) remained disordered and had little interaction with S100B(ββ); therefore, only residues 374-388 of p53 (sequence: GQ STSRH KKLMF KTE) were included in simulations. Removing the extended C-terminal tail also allowed ~25% smaller water boxes to be used. The truncated complex (including all four bound calcium ions) was solvated in TIP3P explicit water. Nine free calcium ions were added to neutralize the total charge. The final solvated system contains ~25,000 atoms in a periodic rectangular box of ~73 Å × 63 Å × 55 Å.
All five solvated initial conformations were equilibrated in CHARMM 50;51 using multiple stages of energy minimization and constant pressure/temperature (NPT) simulation with gradually reducing harmonic positional restraints on the complex. The CHARMM22/CMAP force field [40] [41] [42] was used. After equilibration, five 100-ns NPT production simulations were performed at 300 K and under atmospheric pressure. To prevent global tumbling of the complex (such that a rectangular periodic box could be used), weak harmonic positional restraints with a force constant of 0.1 kcal/mol/Å 2 were placed on the backbone heavy atoms of S100B(ββ) that were at least 10 Å away from any p53 atoms. These harmonic restraints are not expected to affect sampling of p53 conformation and interaction, because the S100B(ββ) dimer should remain stably folded with or without bound p53 32 . SHAKE 52 was applied to constrain the lengths of all bonds involving hydrogen atoms, and a 2.0-fs dynamic time step was used. Particle Mesh Ewald (PME) was used to treat the long-range electrostatic interactoins 53 , and the van der Waals interactions were smoothly switched off from 12 to 13 Å. Snapshots were saved every 2 ps during the production simulations. Because there are two independent p53/S100B(ββ) interfaces in the system, five 100-ns simulations together yield a total of 1.0 μs effective sampling of the p53/S100B(ββ) interaction.
To examine the force field dependence, the minimized structure model 1 of the NMR ensemble was also used to initiate an independent simulation in the Amber ff99SB force field 43 , performed using GROMACS 54 . The protein complex was solvated in a TIP3P cubic box with sides of 70 Å.
Counter ions were added to the system using genion program include with GROMACS program suite. All bonds involving hydrogen atoms were restrained using the SHAKE. PME was used to treat long-range electrostatics, and van de Waals interactions were smoothly switched off at 12 Å. The system was energy minimized, followed by a 20-ns equilibration with a 2-fs time-step.
The production simulation was performed for 100 ns. The simulation trajectory was processed to remove periodic boundary wrapping and converted to the CHARMM format for analysis.
Structural and Clustering Analysis
All structural and clustering analysis were performed using CHARMM, the Multiscale Modeling Tools for Structural Biology (MMTSB) toolset 55 , and in-house scripts. Molecular visualization was generated using VMD 56 . Residue helicity was calculated using the COOR SECS module.
Evolution of RMSD values of various segments, together with helicity analysis, suggests that the complex reached some type of (local) equilibrium after 20-40 ns (e.g., see Fig. S2 and Fig. 3 ).
As such, conformations sampled during the last 60 ns of all five CHARMM trajectories were included in the simulated conformational ensembles of the complex. All clustering and NOE analysis were performed on this ensemble unless otherwise noted. For clustering, the simulated ensemble was first under-sampled by only including snapshots every 100 ps during the last 60 ns of each production trajectory. Each snapshot was then split to generate two independent monomeric p53/S100B(ββ) complex structures. The resulting 6000-member ensemble was clustered using the fixed radius clustering algorithm as implemented in the MMTSB/enscluster.pl tool (with -kclust option). The distance between conformers for clustering was provided by p53 C α RMSD, which was calculated by first aligning the whole monomeric complex using the backbone atoms of S100B(ββ). The RMSD values as calculated reflect differences in both internal conformation and the binding pose of p53-NRD, and will be referred to as "binding RMSD" for the rest of the text. The cutoff radius used in k-mean clustering was empirically selected to be 5 Å. Further NOE and helicity analysis was performed for each of the 10 most populated clusters, which presumably represent key sub-states sampled by p53 when bound to S100B(ββ). It is important to emphasize that conformational sampling achieved in multiple 100-ns explicit solvent simulations remains limited and that the final ensemble as constructed without reweighing independent trajectories is not a rigorous Boltzmann ensemble; therefore, all calculated conformational properties should be considered semi-quantitative, if not only qualitative, estimates.
NOE Violation Analysis
The simulated ensemble was validated mainly through NOE violation analysis. For this, the original NMR restraint data files were downloaded from the direct link provided with the Protein Data Bank entry 1dt7, which included 33 unique intermolecular NOEs for each p53 peptide (see Table 1 ). Coordinates of all the atoms involved in each NOE assignment were extracted from the production trajectories. At each time point, NOE-like distances between two selected atom groups were calculated using the r -weighted nature of NOE averaging renders r NOE highly sensitive to small population of conformations with small r NOE (t) and at the same time rather insensitive to fraction of populations with significantly larger r NOE (t). We also note that protein internal dynamics can modulate the cross relaxation rates and can be included in NOE analysis of continuous MD trajectories 43;58 . The effects of angular fluctuation are ignored in the above analysis due to the need to include conformations sampled from multiple independent simulations. Nonetheless, comparative analysis using the model 1 trajectory suggests that neglecting ps-ns timescale motions in NOE analysis only leads to limited under-estimation of the back-calculated NOE distances (see Table S3 and the following text). Only one monomer of the dimeric complex is highlighted in solid colors. Bound calcium ions are displayed as pink spheres. Key residues of p53 are shown in thick sticks and labeled. All S100B(ββ) residues involved in NOE contacts with the p53 peptide highlighted are shown in thin sticks. Note that two of the intermolecular NOEs involve S100B(ββ) side chains across the symmetric dimer interface (Leu3 and Met7; see Table 1 ). Both residues locate deep at the bottom of the hydrophobic pocket where p53 binds. Four helices (H1-4) of S100B(ββ), together with the hinge between H2 and H3 are also labeled. Table 1 ). Table 1 ). Both p53 monomers were included in calculation of the helicity profile and contact map shown. We largely followed the approach laid out in Bruschweiler et al. (1992) [1] for analyzing the influence of internal dynamics on the NOE distances calculated from the last 60 ns of the 100 ns CHARMM trajectory initiated from model 1 of the NMR ensemble (see the main text). The analysis was performed using a slightly modified version of the CHARMM NMR module [1, 2] .
Briefly, we assumed that the internal and overall motions of the protein are uncoupled, and only internal correlation functions corresponding to individual proton-proton vectors were calculated from the MD trajectory. Most intermolecular NOEs involve groups of multiple hydrogen atoms, particularly one or two methyl groups. Following the work of Schneider et al. (1999) [3], we represented each proton group using the heavy atom nearest to its center of mass to calculate a single internal correlation function for each pairs of proton groups. The generalized order parameters, S 2 , and effective internal correlation time constants, τ e , are given in Table S3 . Given the spectral densities J ij (ω), the cross-relaxation rates between spines i and j are given as,
where ω is the Larmor frequency and γ is the gyromagnetic ratio of protons. In the limit of rigid proteins, the spectral density is given by the Fourier transform of the overall tumbling correlation function (assuming isotropic tumbling),
where τ R is the overall molecular tumbling time constant. The corresponding cross-relaxation rates in the limit of rigid molecular,  ij rigid , can be then calculated by substituting Eq. 2 into Eq. 1.
The effects of internal dynamics on the back-calculated NOE distances are then estimated as: 
The molecular tumbling time was set to be 12.0 ns based on the HYDRONMR analysis of the truncated PDB structure (model 1) [4] . The length of internal correlation functions was set to 12.0 ns (20% of the trajectory length). All relaxation rates were calculated assuming a 600 MHz proton frequency as used in the experimental study [5] .
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